Presentation - Pharma Rep Focus

Which Health Tech Startups Will Present in the Payer/Provider Track of INVEST Pitch Perfect?

MedCity News

APRIL 9, 2024

The post Which Health Tech Startups Will Present in the Payer/Provider Track of INVEST Pitch Perfect? The finalists for the Payer/Provider track are applying their health tech solutions to addressing burnout and operational efficiency. appeared first on MedCity News.

Psychedelics Present Unique Ethical Challenges

Pharmacy Times

APRIL 16, 2024

Sa’ed Al-Olimat, PharmD, co-founder of the Psychedelic Pharmacists Association, discussed the future of psychedelic medicines and the unique ethical challenges they present.

Ethics

Ethics Medicine

Gene therapy for rare muscular dystrophy presents preliminary promise

European Pharmaceutical Review

OCTOBER 30, 2023

At present, there are no curative treatments for LGMD2I/R9. Additionally, these first results were also presented at the 2023 International Limb-Girdle Muscular Dystrophy Conference. According to Atamyo Therapeutics, the condition is characterised by progressive muscular weakness, leading to loss of the ability to walk independently.

Food and Drug Administration

Food and Drug Administration Safety Food FDA

Microbial risks presented by aging facilities

European Pharmaceutical Review

JULY 8, 2022

In an article published in the Journal of Validation Technology (JVT), pharmaceutical microbiologist and contamination control expert Tim Sandle identified ten categories of risk presented by aging. Degradation of the facilities, for instance cracks in walls or tears in material, can also present contamination challenges.

Pharmaceutical

Pharmaceutical Management

Serac to present data from DETECT study

PharmaTimes

JANUARY 19, 2024

Company will present vital findings at SRI annual meeting

Episode 27 – Preparing and Executing Virtual Presentation and Communication Success

Medical Device Success

OCTOBER 11, 2020

Reading time: 2 – 3 minutes In past episodes of the podcast and video cast, we have covered various components of virtual presentations and virtual selling. BrightCarbon is a presentation design company that has worked with life science companies of all sizes to help them communicate their stories and value propositions. .

Doctors

Doctors Medical Sales Marketing

Alzheimer’s senescent cell combination therapy presents promise

European Pharmaceutical Review

SEPTEMBER 7, 2023

The post Alzheimer’s senescent cell combination therapy presents promise appeared first on European Pharmaceutical Review. A larger $3 million, Phase II clinical trial is in process, with the aim to test the effects of clearing senescent cells with the combination therapy, the paper noted.

Food and Drug Administration

Food and Drug Administration Medicine Food FDA

Episode 23 – Making Your Virtual Presentations More Powerful!

Medical Device Success

SEPTEMBER 13, 2020

Virtual presentations are key and you must know how to best use the tools at hand. The post Episode 23 – Making Your Virtual Presentations More Powerful! Virtual presentations are key and you must know how to best use the tools at hand. One of the biggest is the changes in how we communicate.

Medical

Medical Management Marketing Sales

May I Present the Neoantigen

PharmaTech

APRIL 2, 2024

Experts believe it is likely cancer cells are more common in the body than previously thought, but typically caught early and removed in the body’s cancer-immune cycle. When the system is in good working order (and protecting us), dead cancer cells release neoantigens.

Attracting Biotech Investors in a Down Market: Use A Compelling Corporate Presentation

MedCity News

DECEMBER 18, 2022

Many (not all) physician-/scientist-CEOs have a tendency to revert to their area of comfort by using highly scientific terminology and concepts in ways that derail from the purpose of the presentation: articulating the business case in a finite amount of meeting time.

Marketing

Marketing Physicians Biopharma

Virtual Sales Presentation Tips

eatNgage

FEBRUARY 18, 2022

Tips to Ace Your Virtual Sales Presentation. Giving a virtual sales presentation can be nerve-wracking. In this blog post, we will give you tips on how to ace your virtual sales presentation every time! 1) Schedule with your prospect Before you can deliver your presentation, you need an audience to deliver it to!

Sales presentations

Sales presentations Sales Prospecting

The biopharma startups presenting at MedCity INVEST [Sponsored]

MedCity News

MAY 19, 2023

Companies presenting their technology at the conference seek to support a diverse patient population spanning conditions such as inflammatory bowel disease, food allergies, and cancer. Cell, gene therapy and immunotherapies also form some of their treatment approaches in development.

Biopharma

Biopharma Food Patients

Mastering the Art of Presentation: Choosing the Perfect Sample Bag for Pharma Sales Success

Contrarian Sales Techniques

DECEMBER 4, 2023

It’s a mobile showcase, a silent yet persuasive partner in every pitch and presentation. A chaotic bag can lead to a chaotic presentation. In the realm of pharma, where the presentation of drug samples is as critical as the information relayed, these bags serve a pivotal role. The sample bag they carry isn’t just a container.

Sales

Sales Pharmaceutical Sales Ethics Pharma

ACG Inspection Presents New VRS

Pharmaceutical Commerce

DECEMBER 18, 2023

Cloud-based service to address verification of saleable returns under the latest DSCSA regulations.

Interoperability: Past, Present, and Future

MedCity News

JUNE 1, 2023

A new decentralized network of the future exists and is in operation today. Large payers and providers are already beginning to use it for administrative transactions, although clinical transactions are also envisioned.

Networking

AAO 2023: Allgenesis Biotherapeutics presents Phase IIa data of AG-73305 for DME

Pharmaceutical Technology

NOVEMBER 7, 2023

At AAO 2023, results were presented from the Phase IIa trial of Allgenesis’ AG-73305, evaluating its application for the treatment of DME.

Oncolytic viruses: past and present

European Pharmaceutical Review

AUGUST 25, 2022

The post Oncolytic viruses: past and present appeared first on European Pharmaceutical Review. human study of TK?positive positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells. J Transl med. 2019;17:271.

Side effects

Side effects Safety Patients Engineering

High-Risk Pediatric Patients With Antiphospholipid Syndrome Present Risk of Severe Health Issues

Pharmacy Times

DECEMBER 11, 2023

The results found that 93% of individuals in the high-risk group presented persistently positive antiphospholipid antibodies, compared with 47% of individuals in the lower-risk group.

Patients

As FDA weighs another myeloma endpoint for accelerated approvals, experts say timely access is at stake

Fierce Pharma

APRIL 9, 2024

At an FDA advisory committee meeting this Friday, two teams will present their studies examining the utility of minimal residue disease (MRD) as a potentially approvable endpoint in multiple myeloma. About 15 years ago, Carl Ola Landgren, M.D. noticed an encouraging yet potentially concerning trend in the treatment of multiple myeloma. |

FDA

FDA Pharma Patients

JPM24: BioMarin's new CEO Hardy says top priority is expansion of dwarfism drug Voxzogo

Fierce Pharma

JANUARY 10, 2024

In his first presentation as the new CEO of BioMarin, Alexander Hardy left no doubt about his mission for the rare and genetic disease specialist. | In his first presentation as the new CEO of BioMarin, Alexander Hardy left no doubt about his mission for the rare and genetic disease specialist.

Episode 5 – Make Your Virtual PowerPoint Presentation Powerful in this Covid-19 World

Medical Device Success

APRIL 19, 2020

Is a Virtual PowerPoint presentation the same as a face to face PowerPoint? The post Episode 5 – Make Your Virtual PowerPoint Presentation Powerful in this Covid-19 World appeared first on Medical Device Success - Ideas You Can Put To Work Today! Is a Virtual PowerPoint presentation the same as a face to face PowerPoint?

Medical

Medical Sales Management Management Marketing

In downsizing mode, Sage will move headquarters to a smaller space

Fierce Pharma

JANUARY 25, 2024

Two months ago, in presenting quarterly earnings, CEO Barry Greene said Sage Ther | Two months ago, in presenting quarterly earnings, CEO Barry Greene said Sage Therapeutics was on its way to becoming a “leaner and stronger company.”

JPM24: Bristol Myers Squibb CEO Boerner emphasizes organic pipeline over recent M&A deals

Fierce Pharma

JANUARY 8, 2024

It took Bristol Myers Squibb’s new CEO Chris Boerner 16 minutes into his 24-minute presentation to address the big news the company made last month, with its holiday

Novartis’ Pluvicto presents survival benefit for castration-resistant prostate cancer

pharmaphorum

DECEMBER 5, 2022

A vast majority of patients diagnosed with CRPC already present with metastases at the time of diagnosis. The findings will be presented at an upcoming medical meeting and submitted to the FDA for regulatory approval in 2023. Prostate cancer is the most frequently diagnosed cancer in men in 112 countries.

Medicine

Medicine Safety FDA Healthcare

What Was the Most-Repeated Word in CVS Health CEO’s JPM Presentation?

MedCity News

JANUARY 8, 2024

The word has gained greater urgency in recent years as the consumer trend in healthcare has forced payers, providers and all other kinds of healthcare stakeholders to swear by it.

Healthcare

Healthcare Healthcare Retail Biopharma

Pharmaceutical Outsourcing Present and Future

PharmaTech

FEBRUARY 15, 2024

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical

Pharmaceutical Competition Pharma Marketing

Patients With CLL Present Heterogeneously

Pharmacy Times

FEBRUARY 20, 2024

Certain patients may present asymptomatically, affecting treatment options.

Patients

Researchers Present First Study Using Biomimetic AI Digital Twins

PharmExec

MARCH 29, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Anivive Presents First Anti-Fungal Vaccine at World Vaccine Congress

PharmExec

APRIL 5, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Digging Deeper Into Bayer’s ASCO GU Presentation

PharmExec

FEBRUARY 16, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Risk adjusted net present value: What is the current valuation of Novartis’s XXB-750?

Pharmaceutical Technology

APRIL 16, 2024

XXB-750 is a monoclonal antibody commercialized by Novartis, with a leading Phase II program in Systolic Heart Failure.

Leads

Novo, Novartis, BMS and J&J win judge's blessing to combine arguments in upcoming IRA hearing

Fierce Pharma

FEBRUARY 21, 2024

A federal judge in New Jersey agreed to let Bristol Myers Squibb, Novo Nordisk, Novartis and J&J present oral arguments together in their bid to challenge the government's new Medicare negotiations framework.

Government

Eisai’s full lecanemab phase 3 trial results for Alzheimer’s presented at CTAD

pharmaphorum

DECEMBER 2, 2022

Following the news of two lecanemab-related deaths reported on the eve of the Clinical Trials on Alzheimer’s Disease (CTAD) 2022 conference, Eisai has now presented the full results from its phase 3 confirmatory Clarity AD study for early Alzheimer’s disease and published them in the New England Journal of Medicine (NEJM).

Medicine

Medicine Medical Patients

Gerresheimer Presents New Clinical Trial Kit at Pharmapack

PharmaTech

FEBRUARY 1, 2023

Gerresheimer is presenting its new Clinical Trial Kit to accelerate drug development at Pharmapack in Paris.

ESMO: J&J's Rybrevant combo beats Tagrisso on lung cancer progression. Should AZ worry?

Fierce Pharma

OCTOBER 17, 2023

23 when the full data of MARIPOSA are presented at ESMO 2023. | Editor's note: This is an evolving story. Please check back on Oct. A drug combination from Johnson & Johnson outperformed AstraZeneca’s Tagrisso in slowing the worsening of newly diagnosed lung cancer.

Pharma Pulse 4/17/24: At-Home Patients and AI, Psychedelics Present Unique Ethical Challenges & more

Pharmaceutical Commerce

APRIL 17, 2024

The latest news for pharma industry insiders.

Ethics

Ethics Pharma Patients

Risk adjusted net present value: What is the current valuation of Novo Nordisk’s NNC0519-0130?

Pharmaceutical Technology

APRIL 16, 2024

NNC0519-0130 is commercialized by Novo Nordisk, with a leading Phase II program in Type 2 Diabetes.

Leads

Fierce Pharma Asia—Eisai's Leqembi outlook; Sumitomo's downsizing; Kyowa Kirin's expansion

Fierce Pharma

MARCH 7, 2024

In separate updates from Japanese drugmakers, Eisai presented new projections for its Biogen-partnered Alzheimer's disease med Leqmebi, while Sumitomo Pharma initiated a round of layoffs | Eisai presented updated projections for Alzheimer's disease drug Leqembi. Sumitomo Pharma initiated a round of layoffs in the U.S.

Pharma

ESMO: Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer

Fierce Pharma

OCTOBER 18, 2023

22 when the full data of EV-302 are presented at ESMO 2023. | Editor's Note: Please check back on Oct. The results are in for a phase 3 bladder cancer trial assessing the combination of Seagen and Astellas' Padcev, plus Merck's Keytruda, versus standard of care chemotherapy.

Solve the Challenges Presented by B2B Healthcare Marketing

Scott’s Directories

AUGUST 30, 2022

The post Solve the Challenges Presented by B2B Healthcare Marketing first appeared on Canadian Medical Directory Online Database. Conclusion Healthcare marketing is indeed changing, but there are a lot of challenges that B2B companies face as well. That’s where medical database companies can help.

Marketing

Marketing Healthcare Healthcare B2B Sales

Do Direct-to-Consumer Pharmacies Present More Challenges for Patients?

PharmExec

FEBRUARY 29, 2024

Commentary cites lower control over health plan costs and the potential bias for prescribing drugs through influence from drug manufacturers.

Patients

Patients Manufacturing

Risk adjusted net present value: What is the current valuation of Novo Nordisk’s Belcesiran?

Pharmaceutical Technology

MARCH 13, 2024

Belcesiran is an antisense rnai oligonucleotide commercialized by Novo Nordisk, with a leading Phase II program in Alpha-1 Antitrypsin Deficiency (A1AD).

Leads

Personalized Presentations Give Pharma and Med Tech Reps the Edge to Beat the Competition

MobileLocker

NOVEMBER 25, 2020

Find out how some simple customization techniques can help your sales presentations connect with clients and prospects. The post Personalized Presentations Give Pharma and Med Tech Reps the Edge to Beat the Competition appeared first on MobileLocker.

Competition

Competition Sales presentations Pharma Prospecting

Eisai and Biogen present promising lecanemab study results

PharmaTimes

NOVEMBER 30, 2022

Phase 3 research shows that Alzheimer’s disease treatment meets primary and secondary endpoints

Which Health Tech Startups Will Present in the Payer/Provider Track of INVEST Pitch Perfect?

Psychedelics Present Unique Ethical Challenges

Trending Sources

Gene therapy for rare muscular dystrophy presents preliminary promise

Microbial risks presented by aging facilities

Serac to present data from DETECT study

Episode 27 – Preparing and Executing Virtual Presentation and Communication Success

Alzheimer’s senescent cell combination therapy presents promise

Episode 23 – Making Your Virtual Presentations More Powerful!

May I Present the Neoantigen

Attracting Biotech Investors in a Down Market: Use A Compelling Corporate Presentation

Virtual Sales Presentation Tips

The biopharma startups presenting at MedCity INVEST [Sponsored]

Mastering the Art of Presentation: Choosing the Perfect Sample Bag for Pharma Sales Success

ACG Inspection Presents New VRS

Interoperability: Past, Present, and Future

AAO 2023: Allgenesis Biotherapeutics presents Phase IIa data of AG-73305 for DME

Oncolytic viruses: past and present

High-Risk Pediatric Patients With Antiphospholipid Syndrome Present Risk of Severe Health Issues

As FDA weighs another myeloma endpoint for accelerated approvals, experts say timely access is at stake

JPM24: BioMarin's new CEO Hardy says top priority is expansion of dwarfism drug Voxzogo

Episode 5 – Make Your Virtual PowerPoint Presentation Powerful in this Covid-19 World

In downsizing mode, Sage will move headquarters to a smaller space

JPM24: Bristol Myers Squibb CEO Boerner emphasizes organic pipeline over recent M&A deals

Novartis’ Pluvicto presents survival benefit for castration-resistant prostate cancer

What Was the Most-Repeated Word in CVS Health CEO’s JPM Presentation?

Pharmaceutical Outsourcing Present and Future

Patients With CLL Present Heterogeneously

Researchers Present First Study Using Biomimetic AI Digital Twins

Anivive Presents First Anti-Fungal Vaccine at World Vaccine Congress

Digging Deeper Into Bayer’s ASCO GU Presentation

Risk adjusted net present value: What is the current valuation of Novartis’s XXB-750?

Novo, Novartis, BMS and J&J win judge's blessing to combine arguments in upcoming IRA hearing

Eisai’s full lecanemab phase 3 trial results for Alzheimer’s presented at CTAD

Gerresheimer Presents New Clinical Trial Kit at Pharmapack

ESMO: J&J's Rybrevant combo beats Tagrisso on lung cancer progression. Should AZ worry?

Pharma Pulse 4/17/24: At-Home Patients and AI, Psychedelics Present Unique Ethical Challenges & more

Risk adjusted net present value: What is the current valuation of Novo Nordisk’s NNC0519-0130?

Fierce Pharma Asia—Eisai's Leqembi outlook; Sumitomo's downsizing; Kyowa Kirin's expansion

ESMO: Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer

Solve the Challenges Presented by B2B Healthcare Marketing

Do Direct-to-Consumer Pharmacies Present More Challenges for Patients?

Risk adjusted net present value: What is the current valuation of Novo Nordisk’s Belcesiran?

Personalized Presentations Give Pharma and Med Tech Reps the Edge to Beat the Competition

Eisai and Biogen present promising lecanemab study results

Stay Connected